Guthrie R, Susi A.A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 1963;32: 338-343.
2.
Dussault JH, Laberge C.[Thyroxine (T4) determination by radioimmunological method in dried blood eluate: new diagnostic method of neonatal hypothyroidism?] [French]Union Med Can. 1973;10:2062-2064.
3.
American Academy of Pediatrics, Committee on Genetics. Newborn screening fact sheets. Pediatrics. 1996;98:473-501.
4.
Larsson A.Neonatal screening for metabolic, endocrine, infectious, and genetic disorders. Current and future directions. Clin Perinatol. 2001;28:449-461.
5.
American Academy of Pediatrics, Committee on Genetics. New issues in newborn screening for phenylketonuria and congenital hypothyroidism. Pediatrics. 1982;69:104-106.
6.
American Academy of Pediatrics, Section on Endocrinology and Committee on Genetics, and American Thyroid Association Committee on Public Health. Newborn screening for congenital hypothyroidism: recommended guidelines. Pediatrics. 1993; 91:1203-1209.
7.
American Academy of Pediatrics, Committee on Genetics. Issues in newborn screening. Pediatrics. 1992;89:345-349.
8.
American Academy of Pediatrics, Newborn Screening Task Force. Serving the family from birth to the medical home. Newborn screening: a blueprint for the future. A call for a national agenda on State Newborn Screening Programs. Pediatrics. 2000; 106:389-427.
9.
National Screening Committee Health Department UK. First report of the National Screening Committee1998. Available from April 1998: http://www.nsc.nhs.uk/pdfs/nsc_firstreport.pdf.
10.
Seymore CA, Thomason MJ, Chalmers RA, et al.Newborn screening for inborn errors of metabolism: a systematic review. Health Technol Assess. 1997;1:1-95.
11.
Wilson JMG, Jungner G.Principles and Practice of Screening for Disease. Public Health Papers, No. 34. Geneva: World Health Organization; 1968.
12.
Enns GM.Newborn screening by tandem mass spectrometry. NeoReviews. 2001;2:E201-E207.
13.
Scriver CR and Committee. In: Maroid M, Bennett HS, Klingberg MS, Brent RL, Lauder J, Saxen L, eds. Population Screening: Report of a Workshop in Prevention of Physical and Mental Congenital Defects. Part B: Epidemiology, Early Detection and Therapy, and Environmental Factors. New York: Alan R Liss; 1985.
14.
McCabe RE, McCabe L, Mosher GA, et al.Newborn screening for phenylketonuria: predictive validity as a function of age. Pediatrics. 1983;72: 390-398.
15.
Holtzman C, Slazyk WE, Cordero JF, Hannon WH.Descriptive epidemiology of missed cases of phenylketonuria and congenital hypothyroidism. Pediatrics. 1986;78:553-558.
16.
Clayton EW.Issues in state newborn screening programs. Pediatrics. 1992;90:641-646.
17.
Altemeier WA, O’Connor SM, Sherrod KB, Vietze PM.Prospective study of antecedents of nonorganic failure to thrive. J Pediatr. 1985;106:360-365.
18.
Fyra K, Bodegard G.Four-year follow-up of psychological reactions to false positive reactions for congenital hypothyroidism. Acta Pediatr Scand. 1987;76:107-114.
19.
Engel RR.Neonatal clues to maternal diseases. J Okinawa Chubu Hosp. 2001;27:18-24.
